Next 10 |
NEW YORK, July 01, 2024 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today confirmed that it will file its Biologics License Application (BLA) for approval of Ryoncil ® (remestemcel-L) in the treat...
2024-06-16 08:00:00 ET Close on the heels of fellow homebuilder Lennar's ( LEN ) results, KB Home ( KBH ) is set to report its financial figures after the market closes on Tuesday. Analysts are expecting Y/Y declines in both revenue and earnings. ... Read the full article...
Orbital Infrastructure Group Inc. (OIGBQ) is expected to report for Q1 2024 OFS Credit Company Inc. (OCCI) is expected to report for Q2 2024 KBC Groupe NV ADR (KBCSY) is expected to report for Q1 2024 Daikin Industries Ltd ADR (DKILY) is expected to report $0.11 for Q4 2024 Invita...
2024-06-09 08:01:00 ET More on companies reporting earnings during the week FuelCell Energy: Consider Potential Q2 Results Miss And Korean Market Opportunities Oracle: Strong EPS Growth Expected In 2025 And 2026, Watching Q4 Margins (Rating Upgrade) Broadcom: It's To...
NEW YORK, June 02, 2024 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), Chief Executive Silviu Itescu provided a corporate update at the Bell Potter Emerging Leaders Conference. Dr. Itescu reiterated that the Company expects to file this quarter the Biologics License Applicati...
2024-05-28 10:52:47 ET Summary Recent developments, such as the mid-2023 resumption of mining operations by Cleveland-Cliffs on trust leases and the Federal Reserve's reluctance to raise interest rates, suggest potential upside for Mesabi. Increasing odds for a turnaround in China...
NEW YORK, April 29, 2024 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today provided an activity report for the third quarter ended March 31, 2024. Mesoblast Chief Executive Silviu Itescu said: ȁ...
HomeStreet Inc. (HMST) is expected to report $-0.06 for Q1 2024 Kforce Inc. (KFRC) is expected to report $0.58 for Q1 2024 Sun Communities Inc. (SUI) is expected to report $1.16 for Q1 2024 Mynaric AG (MYNA) is expected to report for Q4 2023 Albany International Corporation (AIN) ...
Bank of Hawaii Corporation (BOH) is expected to report $0.92 for Q1 2024 Brown & Brown Inc. (BRO) is expected to report $1.07 for Q1 2024 Independent Bank Group Inc (IBTX) is expected to report $0.57 for Q1 2024 Burnham Holdings Inc - Class A (BURCA) is expected to report for Q1 2...
2024-04-17 08:35:02 ET More on Mesabi Trust Mesabi Trust: Full Production Is Back Despite Cleveland-Cliffs' Ambitions Dividend scorecard for Mesabi Trust Financial information for Mesabi Trust Read the full article on Seeking Alpha For further details...
News, Short Squeeze, Breakout and More Instantly...
NEW YORK, July 01, 2024 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today confirmed that it will file its Biologics License Application (BLA) for approval of Ryoncil ® (remestemcel-L) in the treat...
Orbital Infrastructure Group Inc. (OIGBQ) is expected to report for Q1 2024 OFS Credit Company Inc. (OCCI) is expected to report for Q2 2024 KBC Groupe NV ADR (KBCSY) is expected to report for Q1 2024 Daikin Industries Ltd ADR (DKILY) is expected to report $0.11 for Q4 2024 Invita...
NEW YORK, June 02, 2024 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), Chief Executive Silviu Itescu provided a corporate update at the Bell Potter Emerging Leaders Conference. Dr. Itescu reiterated that the Company expects to file this quarter the Biologics License Applicati...